Last reviewed · How we verify
Polidocanol foam sclerotherapy
Polidocanol foam sclerotherapy is a Small molecule drug developed by Universidade do Porto. It is currently in Phase 2 development. Also known as: Aethoxysklerol 3%).
At a glance
| Generic name | Polidocanol foam sclerotherapy |
|---|---|
| Also known as | Aethoxysklerol 3%) |
| Sponsor | Universidade do Porto |
| Modality | Small molecule |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
- Comparison of Radiofrequency Ablation With Concomitant or Staged Treatment for Tributary Varicose Veins (NA)
- Caprini Score in Venous Surgery: a Prospective Cohort Study
- Polidocanol Foam With or Without Transdermal Laser for Varicose Veins: Randomized Clinical Trial (NA)
- Efficacy of the SALFOAM 3% Method Compared to the Conventional Polidocanol Foam Method (Tessari Method) for Treating Lower Limb Varicose Veins (NA)
- Embolization Strategies for Pelvic Venous Disorders: Foam + Glue vs Foam + Coils (NA)
- Foam and Liquid Sclerotherapy With or Without Herbal Gel for Small Vein Treatment (NA)
- Pilot RCT Evaluating a One Stop Vein Clinic (NA)
- Laser Treatment of Reticular Leg Veins Vs. Sclerotherapy (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Polidocanol foam sclerotherapy CI brief — competitive landscape report
- Polidocanol foam sclerotherapy updates RSS · CI watch RSS
- Universidade do Porto portfolio CI
Frequently asked questions about Polidocanol foam sclerotherapy
What is Polidocanol foam sclerotherapy?
Polidocanol foam sclerotherapy is a Small molecule drug developed by Universidade do Porto.
Who makes Polidocanol foam sclerotherapy?
Polidocanol foam sclerotherapy is developed by Universidade do Porto (see full Universidade do Porto pipeline at /company/universidade-do-porto).
Is Polidocanol foam sclerotherapy also known as anything else?
Polidocanol foam sclerotherapy is also known as Aethoxysklerol 3%).
What development phase is Polidocanol foam sclerotherapy in?
Polidocanol foam sclerotherapy is in Phase 2.
Related
- Manufacturer: Universidade do Porto — full pipeline
- Also known as: Aethoxysklerol 3%)
- Compare: Polidocanol foam sclerotherapy vs similar drugs
- Pricing: Polidocanol foam sclerotherapy cost, discount & access